Sensitivity analysis for primary outcomes
BLOOD, SENSITIVITY
We defined a total dose exceeding 26 g as a surrogate endpoint for IVIG resistance. To test the robustness of this surrogate endpoint, we performed a sensitivity analysis, as shown in Table Sensitivity analysis of definition for primary outcomes.Expressed as n (%), OR, Odds ratio; CI, Confidence interval; IVIG, Intravenous immunoglobulin; TBSF, Taiwan Blood Services Foundation.